Celldex Therapeutics buy Stifel Nicolaus
Start price
18.06.24
/
50%
€33.20
Target price
18.06.25
€54.03
Performance (%)
-45.18%
End price
19.06.25
€18.20
Summary
This prediction ended on 19.06.25 with a price of €18.20. Massive losses of -45.18% were the result for the BUY prediction by Stifel_Nicolaus. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Celldex Therapeutics | -9.735% | -9.735% | -15.702% |
| iShares Core DAX® | -1.553% | -0.123% | 12.654% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.546% |
| iShares Nikkei 225® | 1.640% | 5.468% | 17.939% |
| iShares S&P 500 | 0.114% | -0.217% | 1.586% |
Comments by Stifel_Nicolaus for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $58.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
In the thread Trading Celldex Therapeutics
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten